HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prohibitin 1/2 mediates Dengue-3 entry into human neuroblastoma (SH-SY5Y) and microglia (CHME-3) cells.

AbstractBACKGROUND:
Very few studies have identified receptor molecules for dengue virus (DENV) on neural cells. This study was designed to identify putative receptor/(s) involved in entry of DENV-3 in human neural cells of various lineages; neuronal-SH-SY5Y, astroglial-U-87 MG and microglial-CHME-3 cells.
RESULT:
Virus overlay protein binding assay, LC-MS/MS and SEQUEST identified prohibitin1/2 (PHB1/2) as interacting proteins on SH-SY5Y, CHME-3, and U-87 MG cells. Infection inhibition and siRNA assays confirmed the role of PHB1/2 in the entry of DENV-3 into SH-SY5Y and CHME-3 cells but not in U-87 MG cells. Indirect immunofluorescence and flow-cytometry demonstrated the presence of PHB1/2 on the surface of SH-SY5Y and CHME-3 cells. Co-immunoprecipitation and Western blot, as well as double labelling, reconfirmed the interaction between PHB1/2 and DENV-3 EDIII protein.
CONCLUSION:
These observations together for the first time indicate that PHB1/2 may serve as a putative receptor for DENV-3 in SH-SY5Y and CHME-3 cells. The study provided insights into DENV-3 and neural cell interactions.
AuthorsAmita Sharma, Ravi Vasanthapuram, Manjunatha M Venkataswamy, Anita Desai
JournalJournal of biomedical science (J Biomed Sci) Vol. 27 Issue 1 Pg. 55 (Apr 19 2020) ISSN: 1423-0127 [Electronic] England
PMID32306962 (Publication Type: Journal Article)
Chemical References
  • Membrane Proteins
  • PHB protein, human
  • Prohibitins
  • Receptors, Virus
  • Repressor Proteins
Topics
  • Astrocytes (metabolism)
  • Cell Line
  • Cell Line, Tumor
  • Dengue
  • Dengue Virus (physiology)
  • Humans
  • Membrane Proteins (genetics, metabolism)
  • Microglia (metabolism)
  • Neuroblastoma
  • Prohibitins
  • Receptors, Virus (genetics, metabolism)
  • Repressor Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: